Cargando…
双免疫联合治疗在晚期非小细胞肺癌中的一线应用
Programmed cell death protein-1 (PD-1)/programmed cell death-ligand 1 (PD-L1) inhibitors and PD-1 inhibitors plus chemotherapy combination regimens have been widely used in the first-line treatment of advanced non-small cell lung cancer(NSCLC), but patients with low PD-L1 expression have limited obj...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
中国肺癌杂志编辑部
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8913291/ https://www.ncbi.nlm.nih.gov/pubmed/35224963 http://dx.doi.org/10.3779/j.issn.1009-3419.2021.102.48 |